2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapy.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          An update of the recommendations for the prophylaxis of acute and delayed emesis induced by moderately emetogenic chemotherapy published after the last MASCC/ESMO antiemetic consensus conference in 2009 has been carried out.

          Related collections

          Author and article information

          Journal
          Support Care Cancer
          Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
          Springer Nature America, Inc
          1433-7339
          0941-4355
          January 2017
          : 25
          : 1
          Affiliations
          [1 ] Medical Oncology, Santa Maria Hospital, Via Tristano di Joannuccio 1, 05100, Terni, Italy. roila.fausto@libero.it.
          [2 ] Cancer Clinical Research Unit, Princess Margaret Cancer Centre, Toronto, Canada.
          [3 ] Lahey Health Cancer Institute, Burlington, USA.
          [4 ] Albert Einstein College of Medicine, Jacobi Medical Center, NY, USA.
          [5 ] Department of Oncology, Odense University, 5000, Odense, Denmark.
          [6 ] Department of Hematology/Oncology, Martin Luther University Halle-Wittenberg, Halle, Germany.
          [7 ] Clinique de Genolier, Multidisciplinary Oncology Institute, Genolier, Switzerland.
          [8 ] , Spinetoli, Italy.
          [9 ] Medical Oncology Centre of Rosebank, 129 Oxford Road, Johannesburg, South Africa.
          Article
          10.1007/s00520-016-3365-1
          10.1007/s00520-016-3365-1
          27510316

          Comments

          Comment on this article